The Geneva Papers (2008) 33, 60–65. doi:10.1057/palgrave.gpp.2510162

Solvency II and the Work of CEIOPS

Thomas Steffena

aCEIOPS, Westhafenplatz 1, 60327 Frankfurt am Main, Germany. E-mail: Thomas.Steffen@bafin.de

Top

Abstract

This paper by the Committee of European Insurance and Occupational Pensions Supervisors' (CEIOPS) Chair gives an overview of the main current features of the Solvency II project and CEIOPS work on it, at the time of writing (September 2007). After a brief summary of reasons, drivers and objectives for the proposed new regime, some of the details are described, in terms of CEIOPS' published Advice to the European Commission. Technical provisions, consistency with International Accounting Standards Board, and lead aspects of the three Pillars – solvency capital requirements, minimum capital requirements , internal models, qualitative criteria, supervisory review process, disclosure – are mentioned. CEIOPS' Qualitative Impact Studies are then outlined. The paper concludes with some open political issues.

Keywords:

solvency II, directive, CEIOPS, risk-sensitive, QIS, pensions

MORE ARTICLES LIKE THIS

These links to content published by Palgrave Macmillan are automatically generated.

RESEARCH

Solvency II and the Work of CEIOPS

The Geneva Papers on Risk and Insurance Issues and Practice Original Article

The United States RBC Standards, Solvency II and the Swiss Solvency Test: A Comparative Assessment

The Geneva Papers on Risk and Insurance Issues and Practice Article

A Critical Analysis of the Solvency II Proposals

The Geneva Papers on Risk and Insurance Issues and Practice Article

International Solvency Requirements ? Towards more Risk-based Regimes

The Geneva Papers on Risk and Insurance Issues and Practice Original Article

Towards a Global Approach to Reinsurance Regulation

The Geneva Papers on Risk and Insurance Issues and Practice Original Article

See all 18 matches for Research

Extra navigation

.

Association resources

ADVERTISEMENT
The New Palgrave Dictionary of Economics